Janne Lehtiö

12.9k citations
169 papers · 7.4k indexed · 2 hit papers · h-index 46

Janne Lehtiö

164 papers receiving 7.3k citations

Hit Papers

Cells release subpopulations of exosomes with distinct mo...7432015202620182022200400600

Peers

Janne Lehtiö
Comparison fields: 5 of 153
  • Cancer Research 1.8k
  • Molecular Biology 5.2k
  • Spectroscopy 1.1k
  • Immunology and Allergy 206
  • Immunology 675
Replace Ulrich auf dem Keller with:
Ulrich auf dem Keller Switzerland
Henrik Molina United States
Jau‐Song Yu Taiwan
Lothar Schweigerer Germany
Christian Ihling Germany
Sander R. Piersma Netherlands
Samuel R. Denmeade United States
John F. Timms United Kingdom
James A. Mobley United States
Helmut Klocker Austria
Janne Lehtiö relative to Ulrich auf dem Keller Switzerland Ulrich auf dem Keller's profile →
Citations per field
00.5×1.5×2.3×
Ulrich auf dem Keller · 1×
Citations per year

Countries citing papers authored by Janne Lehtiö

Since Specialization
Citations

This map shows the geographic impact of Janne Lehtiö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janne Lehtiö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janne Lehtiö more than expected).

Fields of papers citing papers by Janne Lehtiö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janne Lehtiö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janne Lehtiö. The network helps show where Janne Lehtiö may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Janne Lehtiö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janne Lehtiö Line = papers co-authored together Janne Lehtiö links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20241
4 20242
5 20241
6 20246
7 20245
8 202316
9 20225
10 20223
11 202115
12 202117
13 202020
14 202024
15 201925
16 201981
17 201919
18 201845
19 201738
20 201728

About Janne Lehtiö

Janne Lehtiö is a scholar working on Spectroscopy, Molecular Biology and Cancer Research, having authored 169 papers that have together received 7.4k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (38 papers), Mass Spectrometry Techniques and Applications (26 papers), Metabolomics and Mass Spectrometry Studies (13 papers), RNA modifications and cancer (12 papers), Molecular Biology Techniques and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), S100 Proteins and Annexins (8 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (5.2k citations) and Spectroscopy (1.1k citations). Janne Lehtiö has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Henrik J. Johansson, Rui M. Branca, Maria Pernemalm, Lukas M. Orre, Rolf Lewensohn, Samir EL Andaloussi, Matthew J. A. Wood, Imre Mäger, Yi Lee and Pieter Vader.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026